Form 4: Pacific Biosciences CEO Christian Henry Sells Shares to Cover Tax Obligations

Christian Henry, CEO of Pacific Biosciences, sold 259,909 shares of common stock on February 18, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Christian Henry, the President & CEO of Pacific Biosciences, sold 259,909 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $1.878, with individual sale prices ranging from $1.80 to $2.00 per share.
• Following the transaction, Henry still beneficially owns 2,237,854 shares of Pacific Biosciences stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover taxes). It's neutral in sentiment as it doesn't inherently indicate positive or negative prospects for the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a high-profile executive could create short-term uncertainty among shareholders.

Key Dates

Keywords

Pacific Biosciences, PACB, Christian Henry, stock sale, Form 4, insider trading, restricted stock units, tax withholding